Navigation Links
Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials

/p>

"EVEREST adds to the collection of data on tolvaptan and its potential uses," said Kazumichi Kobayashi, Chairman & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. "Tolvaptan, as one of our most advanced candidate therapies, exemplifies the successful application of Otsuka's expertise in new drug research and development."

About Heart Failure

More than 14 million people in Europe(6) and five million U.S. residents(7) have heart failure (HF), a serious chronic condition in which the heart cannot effectively pump blood. The direct and indirect U.S. health care expenses related to HF tally about $28 billion, ACC estimates.(5) The majority of patients hospitalized for ADHF, the worsening of chronic HF that affects 1 million US residents annually, have edema or excess body fluid.(3)

About Otsuka Pharmaceutical Development & Commercialization, Inc.

Otsuka Pharmaceutical Development and Commercialization, Inc. is involved in conducting all phases of clinical research and development of innovative healthcare products to address unmet medical needs. OPDC is well established in the scientific community as a globally focused organization that plays a leadership role in the research and development of Otsuka's ethical healthcare products. The Company is dedicated to the improvement of the quality of human life and health of patients around the world with a strong commitment to research and development in the areas of cardiovascular, neuroscience, renal and respiratory diseases, as well as cancer and ophthalmic disorders. OPDC is part of the Otsuka Pharmaceutical Group, which is comprised of 87 companies and approximately 27,000 people around the world. With 44 consolidated subsidiaries, Otsuka earned US $6.8 billion in consolidated annual revenues in fiscal 2005. For additional information, visit www.otsuka.com.

JAMA Publications:

Konstam, MA, et
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
2. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
7. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
8. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
9. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
10. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
11. UCB Presents Long-Term CImzia Data in Crohns Disease
Post Your Comments:
(Date:10/18/2014)...  In a policy paper released ... largest lesbian, gay, bisexual and transgender (LGBT) civil ... for Pre-Exposure Prophylaxis (PrEP). PrEP is any medical ... spread of a disease or infection prior to ... drug combination currently approved for PrEP, which protects ...
(Date:10/17/2014)...  Amgen (NASDAQ: AMGN ) today announced ... president of Gladstone Institutes and Gladstone,s Robert W. and ... are pleased to welcome Dr. Sandy Williams ... , chairman and chief executive officer of Amgen. "Dr. ... his direct experience in our industry will both be ...
(Date:10/17/2014)... 2014 According to ... Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic ... Neurology, Oncology, Cardiology) - Global Forecasts to ... Optical Imaging market over the forecast period ... $917.1 million in 2014 and is expected ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4
(Date:10/20/2014)... October 20, 2014 ASCNYC (ascnyc.org) ... that helps New Yorkers living with HIV/AIDS and ... health, housing, recovery and self-sufficiency. Each year, ASCNYC ... local community through their tireless efforts. , ... Shapses , has been selected as this year’s ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Zereana Jess-Huff, a ... Mrs. Maryland 2014 on a platform to think outside the ... and uses her position to raise awareness about women’s other ... for breast cancer. You say the color pink and everybody ... know for a fact that it has not been won ...
(Date:10/20/2014)... CA (PRWEB) October 20, 2014 AttorneyOne.com, a ... the latest information from the FDA on Sit and ... October 10 not to purchase or use Sit and Slim ... and Slim II is promoted as weight loss product on ... removed from the market in 2010 for safety reasons, can ...
(Date:10/20/2014)... October 20, 2014 Based on ... the only imaging assays capable of determining DNA ... test.  With these three dimensions of high-resolution data, ... detect the widest range of disease-causing genetic rearrangements, ... by other genomic tools, including today’s advanced sequencing ...
(Date:10/20/2014)... DALLAS (PRWEB) October 20, 2014 It’s hard ... for many orphans and vulnerable children around the world, it’s ... by some people, many children are forced to walk barefoot ... for their families or play with their friends. , ... partnering with Air1 Radio in October to encourage ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3
... A new report released Wednesday,February 11, 2009 by ... physical activity, Special Olympics athletes are more physically active,than ... , U.S. Vice President Joe ... Winter Games in Boise, Idaho on Thursday, February 12, ...
... Virtua Health has responded to the public regarding legal action ... Court judge ordered Virtua to stop its Top Doc advertising ... advertising statements are fraudulent. Cooper also sent an e-mail to ... "Virtua has always had the highest ethical standards and ...
... , ... Eagan, MN (Vocus) February 11, 2009 -- Employees of DeCare ... Northeastern Minnesota. A company cookbook was created and recipes were gathered ... than 200 cookbooks were sold. , , , , ,"After years ...
... Feb. 11 Cogdell Spencer Inc. (NYSE:, CSA ... of the Northwest,Region for the Company,s wholly owned subsidiary, ... Based in the Company,s Seattle office, Mr. Aigner ... be responsible for all,design-build and development projects in the ...
... with salivary gland , , WEDNESDAY, Feb. 11 (HealthDay News) -- A ... who blew his tuba so hard that he sent air into ... the condition after the boy developed swelling and pain around his ... Deepa Mukundan, who wrote about the case in the Feb. 12 ...
... ("Transition" or the "Company") (TSX: TTH; NASDAQ: ... disease indications with large markets, today announced its financial ... Selected Highlights, -------------------, ... and up to the date of this press,release, the ...
Cached Medicine News:Health News:Special Olympics Issues Report on the Impact of Special Olympics Healthy Athletes Initiative to show Need for Reauthorization of the Special Olympics Sport and Empowerment Act of 2004 2Health News:Special Olympics Issues Report on the Impact of Special Olympics Healthy Athletes Initiative to show Need for Reauthorization of the Special Olympics Sport and Empowerment Act of 2004 3Health News:Virtua Health Responds to Court Order 2Health News:Company Cookbook Proceeds to Benefit United Way of Northeastern Minnesota 2Health News:Cogdell Spencer Announces Aigner as President in the Northwest Region 2Health News:Cogdell Spencer Announces Aigner as President in the Northwest Region 3Health News:Tuba Spells Trouble for Young Musician 2Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 2Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 3Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 4Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 5Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 6Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 7Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 8Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 9Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 10Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 11Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 12Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 13Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 14Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 15
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
... Tip flattened and angled 90 1.0mm from end, ... lock high pressure extension tubing set, Capable of ... OD- 1.5mm (.06 in) long luer lock, high ... tubing. Bend 1.0mm from end. (Cannulas ...
Rounded tip for even incisions reducing post-op astigmatism...
Stab incision blades color coded for simple and accurate identification...
Medicine Products: